当前位置:首页 - 行情中心 - 万泰生物(603392) - 财务分析 - 利润表

万泰生物

(603392)

  

流通市值:736.30亿  总市值:736.30亿
流通股本:12.65亿   总股本:12.65亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入843,561,860.09400,625,153.872,245,403,245.651,948,111,396.63
  营业收入843,561,860.09400,625,153.872,245,403,245.651,948,111,396.63
二、营业总成本1,020,748,464.07464,970,086.222,395,621,317.621,928,979,981.89
  营业成本334,452,600.67134,003,165.48759,044,722.33548,825,057.73
  税金及附加11,084,588.32,204,754.8223,100,236.8914,267,199.93
  销售费用217,080,093.66103,473,018.76438,392,131.59443,746,679.62
  管理费用192,690,508.2192,912,751.33347,100,195.32237,739,182.71
  研发费用276,466,361.42138,625,170.95886,051,943.23726,214,438.31
  财务费用-11,025,688.19-6,248,775.12-58,067,911.74-41,812,576.41
  其中:利息费用13,605,360.72,026,170.058,324,928.734,368,762.54
  其中:利息收入25,462,600.156,681,311.3359,455,687.1350,024,611.21
三、其他经营收益
  加:公允价值变动收益17,591,273.788,817,746.1536,707,335.7613,336,212.46
  加:投资收益44,357,628.6522,017,103.25109,636,079.1193,453,414.67
  资产处置收益-146,644.6-15,909.997,923,472.521,183,739.81
  资产减值损失(新)-23,426,159.84-5,497,838.89-103,626,312.79-10,588,103.27
  信用减值损失(新)-57,429,999.74-45,828,090.79-17,171,300.92-25,470,766.68
  其他收益56,896,996.4329,055,479.16210,586,461.02173,426,761.91
四、营业利润-139,343,509.3-55,796,443.4693,837,662.73264,472,673.64
  加:营业外收入588,873.86135,532.112,629,833.14275,756.32
  减:营业外支出6,928,222.472,239,304.5528,986,662.9918,596,119.33
五、利润总额-145,682,857.91-57,900,215.967,480,832.88246,152,310.63
  减:所得税费用-190,628.13-3,758,229.48-41,613,689.49-24,333,825.64
六、净利润-145,492,229.78-54,141,986.42109,094,522.37270,486,136.27
(一)按经营持续性分类
  持续经营净利润-145,492,229.78-54,141,986.42109,094,522.37270,486,136.27
(二)按所有权归属分类
  归属于母公司股东的净利润-144,038,127.02-52,776,946.91106,235,425.64266,649,096.74
  少数股东损益-1,454,102.76-1,365,039.512,859,096.733,837,039.53
  扣除非经常损益后的净利润-242,605,985.91-105,032,198.13-186,442,703.940,996,003.75
七、每股收益
  (一)基本每股收益-0.11-0.040.080.21
  (二)稀释每股收益-0.11-0.040.080.21
九、综合收益总额-145,492,229.78-54,141,986.42109,094,522.37270,486,136.27
  归属于母公司股东的综合收益总额-144,038,127.02-52,776,946.91106,235,425.64266,649,096.74
  归属于少数股东的综合收益总额-1,454,102.76-1,365,039.512,859,096.733,837,039.53
公告日期2025-08-212025-04-252025-04-122024-10-25
审计意见(境内)标准无保留意见
TOP↑